Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Chemotherapy for Malignant Germ Cell Ovarian Cancer in Adult Patients With Early Stage, Advanced and Recurrent Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439655/all/Xpert_MTB_RIF_and_Xpert_MTB_RIF_Ultra_assays_for_active_tuberculosis_and_rifampicin_resistance_in_children_New.
Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439655/all/Xpert_MTB_RIF_and_Xpert_MTB_RIF_Ultra_assays_for_active_tuberculosis_and_rifampicin_resistance_in_children_New. Accessed July 17, 2025.
Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439655/all/Xpert_MTB_RIF_and_Xpert_MTB_RIF_Ultra_assays_for_active_tuberculosis_and_rifampicin_resistance_in_children_New
Chemotherapy for Malignant Germ Cell Ovarian Cancer in Adult Patients With Early Stage, Advanced and Recurrent Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 July 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439655/all/Xpert_MTB_RIF_and_Xpert_MTB_RIF_Ultra_assays_for_active_tuberculosis_and_rifampicin_resistance_in_children_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease
ID - 439655
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439655/all/Xpert_MTB_RIF_and_Xpert_MTB_RIF_Ultra_assays_for_active_tuberculosis_and_rifampicin_resistance_in_children_New
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -